|
Edan Instruments, Inc. (300206.SZ) Évaluation DCF
CN | Healthcare | Medical - Devices | SHZ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Edan Instruments, Inc. (300206.SZ) Bundle
Explorez les prospects financiers d'Edan Instruments, Inc. (300206SZ) avec notre calculatrice DCF conviviale! Entrez simplement vos prévisions de croissance, de marges et de dépenses pour déterminer la valeur intrinsèque d'Edan Instruments, Inc. (300206SZ) et façonner votre plan d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,136.2 | 2,318.6 | 1,636.4 | 1,742.4 | 1,938.0 | 2,145.9 | 2,376.0 | 2,630.9 | 2,913.1 | 3,225.6 |
| Revenue Growth, % | 0 | 104.06 | -29.42 | 6.48 | 11.22 | 10.73 | 10.73 | 10.73 | 10.73 | 10.73 |
| EBITDA | 139.3 | 794.2 | 304.4 | 300.3 | 281.0 | 415.6 | 460.2 | 509.6 | 564.3 | 624.8 |
| EBITDA, % | 12.26 | 34.25 | 18.6 | 17.24 | 14.5 | 19.37 | 19.37 | 19.37 | 19.37 | 19.37 |
| Depreciation | 40.6 | 45.4 | 52.5 | 57.0 | 55.0 | 63.7 | 70.6 | 78.1 | 86.5 | 95.8 |
| Depreciation, % | 3.57 | 1.96 | 3.21 | 3.27 | 2.84 | 2.97 | 2.97 | 2.97 | 2.97 | 2.97 |
| EBIT | 98.7 | 748.7 | 251.9 | 243.3 | 226.0 | 351.9 | 389.7 | 431.5 | 477.7 | 529.0 |
| EBIT, % | 8.69 | 32.29 | 15.39 | 13.97 | 11.66 | 16.4 | 16.4 | 16.4 | 16.4 | 16.4 |
| Total Cash | 466.4 | 1,058.3 | 834.7 | 957.0 | 941.7 | 1,035.2 | 1,146.3 | 1,269.2 | 1,405.4 | 1,556.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 129.7 | 155.5 | 91.0 | 129.3 | 144.7 | 165.5 | 183.3 | 203.0 | 224.7 | 248.8 |
| Account Receivables, % | 11.41 | 6.71 | 5.56 | 7.42 | 7.47 | 7.71 | 7.71 | 7.71 | 7.71 | 7.71 |
| Inventories | 198.9 | 355.6 | 398.2 | 430.0 | 400.4 | 440.0 | 487.2 | 539.4 | 597.3 | 661.3 |
| Inventories, % | 17.5 | 15.34 | 24.34 | 24.68 | 20.66 | 20.5 | 20.5 | 20.5 | 20.5 | 20.5 |
| Accounts Payable | 101.2 | 126.6 | 113.6 | 130.7 | 90.3 | 143.7 | 159.1 | 176.1 | 195.0 | 215.9 |
| Accounts Payable, % | 8.91 | 5.46 | 6.94 | 7.5 | 4.66 | 6.69 | 6.69 | 6.69 | 6.69 | 6.69 |
| Capital Expenditure | -52.9 | -49.1 | -73.6 | -42.4 | -51.1 | -70.1 | -77.6 | -86.0 | -95.2 | -105.4 |
| Capital Expenditure, % | -4.66 | -2.12 | -4.49 | -2.43 | -2.64 | -3.27 | -3.27 | -3.27 | -3.27 | -3.27 |
| Tax Rate, % | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 | 0.05734367 |
| EBITAT | 101.9 | 651.7 | 235.8 | 232.5 | 225.8 | 335.1 | 371.1 | 410.9 | 454.9 | 503.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -137.8 | 490.9 | 223.7 | 194.2 | 203.5 | 321.7 | 314.5 | 348.2 | 385.5 | 426.9 |
| WACC, % | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,526.3 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 440 | |||||||||
| Terminal Value | 18,342 | |||||||||
| Present Terminal Value | 14,102 | |||||||||
| Enterprise Value | 15,629 | |||||||||
| Net Debt | -924 | |||||||||
| Equity Value | 16,553 | |||||||||
| Diluted Shares Outstanding, MM | 580 | |||||||||
| Equity Value Per Share | 28.55 |
What You Will Receive
- Authentic Edan Data: Comprehensive financials – covering everything from revenue to EBIT – derived from actual and projected figures.
- Complete Customization: Modify all essential parameters (highlighted cells) such as WACC, growth %, and tax rates.
- Immediate Valuation Updates: Automatic recalibrations to assess the effect of modifications on Edan’s fair value.
- Flexible Excel Template: Designed for rapid adjustments, scenario analysis, and detailed forecasting.
- Efficient and Precise: Eliminate the need to construct models from scratch while ensuring accuracy and adaptability.
Key Features
- Real-Time 300206SZ Data: Pre-populated with Edan Instruments’ historical financial performance and future projections.
- Completely Customizable Inputs: Tailor revenue growth rates, profit margins, WACC, tax rates, and capital expenditures to your needs.
- Adaptive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on your specified inputs.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- Intuitive Interface: Designed to be straightforward and accessible for both professionals and novices.
How It Works
- 1. Access the Template: Download and open the Excel file containing Edan Instruments, Inc.'s preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Assurance: Deliver professional valuation insights to back your investment decisions.
Why Choose Edan Instruments, Inc. (300206SZ) Calculator?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses conveniently combined.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically determines Edan's intrinsic value and Net Present Value.
- Preloaded Information: Access historical and projected data for accurate benchmarking.
- High-Quality Standards: Perfect for financial analysts, investors, and business advisors.
Who Can Benefit from This Product?
- Healthcare Students: Understand medical device evaluation techniques and apply them with real-world data.
- Researchers: Integrate cutting-edge models into your studies or projects.
- Investors: Validate your hypotheses and assess valuation results for Edan Instruments, Inc. (300206SZ).
- Market Analysts: Enhance your efficiency with a ready-to-use, customizable financial model.
- Healthcare Professionals: Discover how leading companies like Edan Instruments, Inc. (300206SZ) are analyzed in the market.
Contents of the Template
- Pre-Filled Data: Includes Edan Instruments' historical financial data and projections.
- Discounted Cash Flow Model: An editable DCF valuation model with automatic calculations included.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Edan Instruments' profitability, efficiency, and financial leverage.
- Customizable Inputs: Easily adjust revenue growth rates, profit margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.